INVESTORS

ANNUAL REPORT

Annual Report - Concord Biotech Limited

ANNUAL RETURN

JOINT VENTURE FINANCIAL INFORMATION

MATERIAL CREDITORS

POLICIES

Prospectus

Intimation to Stock Exchange

Intimation about closure of USFDA Inspection at Limbasi (Unit III)

Intimation regarding the resignation of Mr. Amit Varma (Director)

Intimation regarding the resignation of Mr.Anil Katyal (Independent Director)

Intimation of Board Meeting of Concord Biotech Limited

Intimation for Earning Call for Q1FY24 of Concord Biotech Limited

Outcome of Board Meeting Dated 6th September 2023

Intimation of Presentation for Q1FY24

Q1FY24 Earning Call Audio

Intimation for Press Release Q1 FY2024

Q1FY24 Intimation of Earning Call Transcript

Intimation of Resignation of Director

Corporate Governance Report

Shareholding Pattern as on 30th september 2023

Intimation of Board Meeting of Concord Biotech Limited for Q2 FY24

Concord Intimation of earning call Final

Outcome of Board meeting for Q2FY 24 Dated 08th Novemeber 2023

Intimation of Press release Q2 FY 24

Intimation of Investor Presentation Q2 FY24

Transcripts of Q2 & H1 FY24 Earnings call

RPT_30.09.2023_CBL

Intimation of Schedule of Institutional Investor meetings on 24th November 2023

Intimation of Schedule of Institutional Investor meetings 19th to 22 December 2023

Corporate Governance Report

Shareholding Pattern as on 31st December 2023

Prior Intimation of BM 08-02-2024

Intimation of Earning Call Q3 9M 2023-24

Outcome of BM 08-02-2024

Intimation of investor Presentation Q3 9M 24

Earning Call Outcome Q3 9M FY24

Press Release Intimation 08-02-2024

Intimation Conference Meet 20-02-2024

Intimation of Earning Call Transcript Q3 9M FY 2024

Shareholding Pattern as on 31-03-2024

Corporate Governance 31-03-2024

Investors Presentation

Newspaper Release